Medicare Enrolled

Dr. Charles Accurso, M.D.

Optician · Hillsborough, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
511 COURTYARD DR, Hillsborough, NJ 08844
9082189222
In practice since 2005 (20 years)
NPI: 1710963533 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Accurso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Accurso? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Accurso

Dr. Charles Accurso is an optician specialist in Hillsborough, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Accurso performed 1,021 Medicare services across 893 unique beneficiaries.

Between the years covered by Open Payments, Dr. Accurso received a total of $1,920 from 23 pharmaceutical and/or device companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Accurso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 50% volume in NJ $1,920 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,021
Medicare services
Top 50% in NJ for optician
893
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
208 $100 $302
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
111 $73 $240
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
107 $130 $477
Stool test for hidden blood (FIT)
A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method.
91 $15 $147
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
79 $232 $2,124
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
78 $75 $1,224
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
68 $123 $1,552
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
67 $1 $30
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
35 $124 $1,218
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
34 $201 $1,390
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
27 $81 $333
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
25 $127 $1,245
Liver stiffness measurement
A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring.
25 $28 $450
Complete ultrasound of abdomen
A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen.
21 $104 $450
Colonoscopy
A diagnostic exam of the lower portion of the large bowel using a flexible endoscope.
18 $172 $762
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
15 $75 $1,071
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
12 $202 $1,390
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.0% high complexity
24.1% medium
65.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,920
Total received (2018-2024)
Avg $274/year across 7 years
Top 34% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
125
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,878 (97.8%)
Other
Charitable contributions, space rental, and other categories
$42 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$363
2023
$241
2022
$265
2021
$179
2020
$134
2019
$195
2018
$543

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$101
ABBVIE INC.
$87
PENTAX of America, Inc.
$42
IRONWOOD PHARMACEUTICALS, INC
$36
Lilly USA, LLC
$34
Ardelyx, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$20
Ipsen Biopharmaceuticals, Inc
$20
Top 3 companies account for 63.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$365
ABBVIE INC.
$256
AbbVie Inc.
$236
Ethicon US, LLC
$139
AbbVie, Inc.
$137
GENZYME CORPORATION
$121
Synergy Pharmaceuticals Inc
$70
PFIZER INC.
$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$68
QOL Medical, LLC
$63
Takeda Pharmaceuticals U.S.A., Inc.
$48
Ardelyx, Inc.
$44
Allergan Inc.
$43
PENTAX of America, Inc.
$42
IRONWOOD PHARMACEUTICALS, INC
$36
Lilly USA, LLC
$34
Ironwood Pharmaceuticals, Inc
$31
Daiichi Sankyo Inc.
$29
Merck Sharp & Dohme Corporation
$27
Ipsen Biopharmaceuticals, Inc
$20
Celgene Corporation
$15
Medtronic, Inc.
$14
Allergan, Inc.
$13
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
Bylvay · DIFICID · DUPIXENT · Dexilant · ENDO STRATUS CO2 Insufflator · ENTYVIO · GI GENIUS · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · Mavyret · Movantik · OMVOH · RELISTOR ORAL · REMICADE · RINVOQ · SKYRIZI · STELARA · Sucraid · Trulance · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Hillsborough?
Compare opticians in the Hillsborough area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
648
Per 100K population
187.2
County median income
$135,960
Nearest hospital
HACKENSACK MERIDIAN HEALTH CARRIER CLINIC
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Accurso is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Accurso experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Accurso performed 208 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Accurso receive payments from pharmaceutical companies?
Yes. Dr. Accurso received a total of $1,920 from 23 companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Accurso's costs compare to other opticians in Hillsborough?
Dr. Accurso's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Accurso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →